The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy.
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
4
Citations
NaN
KQI